Jason Tardio

Jason Tardio

Chief Operating Officer at OVID THERAPEUTICS INC.

Net worth: 85 781 $ as of 2024-03-30

47 year
Health Technology
Consumer Services

Profile

Jason Tardio's career history includes current and former positions as well as his education.
Currently, he is the Chief Operating Officer at Ovid Therapeutics, Inc. Prior to this, he held the position of General Manager & MD-Latin America South at Biogen, Inc. from 2017 to 2018.
He also served as the VP & Head-Multiple Sclerosis Franchise at Novartis, Inc. in 2019.
In terms of education, Mr. Tardio obtained an undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-21 28,125 ( 0.04% ) 85 781 $ 2024-03-30

Jason Tardio active positions

CompaniesPositionStart
OVID THERAPEUTICS INC. Chief Operating Officer 2021-07-07
All active positions of Jason Tardio

Former positions of Jason Tardio

CompaniesPositionEnd
Corporate Officer/Principal 2019-10-31
BIOGEN INC. Corporate Officer/Principal 2018-08-31
See the detail of Jason Tardio's experience

Training of Jason Tardio

The College of New Jersey Undergraduate Degree
St. Joseph's University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jason Tardio's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BIOGEN INC.

Health Technology

OVID THERAPEUTICS INC.

Health Technology

Private companies1

Health Technology

See company connections